Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Guillon

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Molecular Biology|November 2, 2010
Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallographyJennifer Serrière, Jean-Marc Dugua, Marc Bossus, et al.
Journal of Virology|February 28, 2002
Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interactionChristophe Guillon, Martin Schutten, Patrick H M Boers, et al.
Trends in Immunology|September 26, 2002
The choice of antigen for therapeutic immunization against AIDSCarel A van Baalen, Koert J Stittelaar, Albert D M E Osterhaus, et al.
Vaccine|October 2, 2007
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbitsChristophe Guillon, Katia Mayol, Céline Terrat, et al.
Future Medicinal Chemistry|March 2, 2021
Pyrazol(in)e derivatives of curcumin analogs as a new class of anti-<i>Trypanosoma cruzi</i> agentsDimitris Matiadis, Tatiana Saporiti, Elena Aguilera, et al.
AIDS Research and Human Retroviruses|May 31, 2002
Adaptive changes after human immunodeficiency virus type 1 transmissionVictoria A Lawson, Robert Oelrichs, Christophe Guillon, et al.
Biochemistry|June 7, 2021
Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding SiteMathieu Long, François-Xavier Cantrelle, Xavier Robert, et al.
Journal of Virological Methods|October 31, 2001
Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in NefChristophe Guillon, Carel A van Baalen, Patrick H M Boers, et al.
Frontiers in Immunology|July 18, 2017
Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses <i>In Vivo</i>Bernard Verrier, Stéphane Paul, Céline Terrat, et al.
Biochemical and Biophysical Research Communications|April 16, 2025
Integrating different approaches for the identification of new disruptors of HIV-1 capsid multimerizationZoraima Artía, Christophe Guillon, Xavier Robert, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Molecular Biology|November 2, 2010
Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallographyJennifer Serrière, Jean-Marc Dugua, Marc Bossus, et al.
Journal of Virology|February 28, 2002
Antibody-mediated enhancement of human immunodeficiency virus type 1 infectivity is determined by the structure of gp120 and depends on modulation of the gp120-CCR5 interactionChristophe Guillon, Martin Schutten, Patrick H M Boers, et al.
Trends in Immunology|September 26, 2002
The choice of antigen for therapeutic immunization against AIDSCarel A van Baalen, Koert J Stittelaar, Albert D M E Osterhaus, et al.
Vaccine|October 2, 2007
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbitsChristophe Guillon, Katia Mayol, Céline Terrat, et al.
Future Medicinal Chemistry|March 2, 2021
Pyrazol(in)e derivatives of curcumin analogs as a new class of anti-<i>Trypanosoma cruzi</i> agentsDimitris Matiadis, Tatiana Saporiti, Elena Aguilera, et al.
AIDS Research and Human Retroviruses|May 31, 2002
Adaptive changes after human immunodeficiency virus type 1 transmissionVictoria A Lawson, Robert Oelrichs, Christophe Guillon, et al.
Biochemistry|June 7, 2021
Identification of a Potential Inhibitor of the FIV p24 Capsid Protein and Characterization of Its Binding SiteMathieu Long, François-Xavier Cantrelle, Xavier Robert, et al.
Journal of Virological Methods|October 31, 2001
Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in NefChristophe Guillon, Carel A van Baalen, Patrick H M Boers, et al.
Frontiers in Immunology|July 18, 2017
Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses <i>In Vivo</i>Bernard Verrier, Stéphane Paul, Céline Terrat, et al.
Biochemical and Biophysical Research Communications|April 16, 2025
Integrating different approaches for the identification of new disruptors of HIV-1 capsid multimerizationZoraima Artía, Christophe Guillon, Xavier Robert, et al.
Pageof 4